#braincancerresearch
As we approach the end of the year, the team at CANON wishes everyone a happy holidays! ❄️✨ We hope you stay warm, healthy, and safe.

#CANON #AYA #CNS #BrainCancerResearch #Hope
December 15, 2025 at 2:33 PM
Great news from MIT! 🧪 Their chemists have synthesized a fungal compound showing incredible promise for treating brain cancer, offering a new beacon of hope for future therapies. #ScienceNews #BrainCancerResearch #MedicalBreakthrough 🍄🧠
MIT chemists synthesize a fungal compound that holds promise for treating brain cancer
news.mit.edu
December 6, 2025 at 7:00 PM
Great to have everyone together for our company offsite yesterday! It’s always great to connect as a full team, celebrate our wins, and align on the next phase of our journey 🙌🧠🚀

#CoSyneTherapeutics #Glioblastoma #Bioinformatics #DrugDiscovery #BrainCancerResearch
October 9, 2025 at 2:40 PM
MYTH vs FACT: Think you know the truth about brain cancer? Let’s break down some common misconceptions! 🧠

Have you heard this myth before? 💭⁉️

#Glioblastoma #GBM #BrainCancer #BrainCancerResearch #BioTech
September 30, 2025 at 12:39 PM
A huge congratulations to our bioinformatician Grant who conquered the great Steall Marathon in the Scottish Highlands on the weekend! He finished with an impressive time of 7:03 and placed 85 of 231 finishers. 🏃 🏔️ 🎖️

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #Fundraising
September 23, 2025 at 4:16 PM
🔔 Don't miss a thing! Our journey to fight rare neurological disease is happening on all our social media channels, and we'd love for you to join us.
➕ Follow us on all our pages to get the full story and support our mission.
#Glioblastoma #DrugDiscovery #BrainCancerResearch
September 18, 2025 at 10:31 AM
We’ve got an incredible interdisciplinary team here at CoSyne; Jo is our experimental biology lead based in our wet lab in Cambridge, and Gui is an engineer who integrates the data generated by our wet lab and computational teams 🔬🥼🖥️🧬

#GBM #Bioinformatics #DrugDiscovery #BrainCancerResearch
August 29, 2025 at 2:04 PM
CoSyne is dedicated to changing the narrative around brain cancer. Our multidisciplinary team is focused on identifying vulnerabilities in this complex disease, pushing the boundaries of research to develop effective treatments.

#GBM #BrainCancerResearch #DrugDiscovery #BioTech
August 26, 2025 at 2:22 PM
We’ve got an incredible interdisciplinary team here at CoSyne; Grant and Gregor analyse our genomic data generated in the wet lab, and identify potential drug targets based on this data and other available literature 🖥️🧬🎯

#Glioblastoma #Bioinformatics #DrugDiscovery #BrainCancerResearch
August 22, 2025 at 1:53 PM
Behind the scenes: our team of bioinformaticians is diving deep into biological data, using cutting-edge analysis to uncover potential new drugs for GBM. Data-driven discovery at its finest! 🔬

#CoSyneTherapeutics #GBM #Bioinformatics #DrugDiscovery #BrainCancerResearch
August 20, 2025 at 9:22 AM
A new clinical trial is recruiting patients with glioblastoma — the most aggressive brain tumor in adults. KSAT’s The Conversation talks to Dr. Andrew Brenner about the study and how patients can get involved. #Glioblastoma #ClinicalTrial #BrainCancerResearch
youtu.be/5Vm95A-zVcE?...
The Conversation: Mays Cancer Center recruiting glioblastoma patients for trial
YouTube video by KSAT 12
youtu.be
August 13, 2025 at 2:53 PM
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma (GBM) patients.

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
August 12, 2025 at 12:38 PM
🧠✨This study is the first to clearly demonstrate the presence of growth-promoting synaptic communication between GABAergic neurons and H3K27M+ DMG cells

📍Learn more:
www.ebraincase.com/support/lite...

www.nature.com/articles/s41...

#Neuroscience #BrainCancerResearch #Glioma #BrainCaseBiotech
Literature Review | Major Nature Discovery: GABAergic Neurons Drive Diffuse Midline Glioma Growth via Synaptic Signaling
Nature study reveals GABAergic synapses between neurons and H3K27M+ DMG cells promote tumor growth, offering new insights for brain cancer therapy.
www.ebraincase.com
August 11, 2025 at 7:36 AM
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.

Read more about our work on our website: www.cosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
August 5, 2025 at 1:53 PM
For diseases like GBM, where treatment options remain limited, every insight counts. [14/14]

#Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
July 31, 2025 at 12:54 PM
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.

Read more about our work on our website: www.cosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
July 29, 2025 at 12:32 PM
CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.

Read more about our work on our website: www.cosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
July 22, 2025 at 1:19 PM
GBM patients have faced decades without a new approved therapy.

At CoSyne, we’re working on something that could change that. Stay tuned.

www.gliosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
July 18, 2025 at 1:36 PM
The last FDA-approved therapy for glioblastoma (GBM) was in 2009.

15 years with no new treatments — patients deserve better.

Follow us for updates on what we're doing to bring new treatments to patients.

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech
July 17, 2025 at 1:35 PM
Only 1% of the UK’s yearly cancer research budget goes to brain cancer. In just 3 years, CoSyne Therapeutics has directed £6M into brain cancer research - driving novel insights and pushing the field forward.

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery
July 15, 2025 at 1:14 PM
Cells aren’t the only thing we grow at CoSyne Therapeutics – this year we are taking part in a chilli growing contest! We have lots of plants to brighten our office space in Cambridge.

#CosyneTherapeutics #BrainCancerResearch #DrugDiscovery #Biotech
July 11, 2025 at 12:36 PM